SHW

Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis

Product code
SHW
Device name
Pathology Software Algorithm Device Analyzing Digital Images For Breast Cancer Prognosis
Device class
Class 2
21 CFR
21 CFR 864.3755
Medical specialty
Pathology
Marketing pathway
510(K)
510(k) clearances (last 3 years)
1

FDA classification definition

A pathology software algorithm device analyzing digital images for cancer prognosis is a software intended to analyze scanned whole slide images (WSIs) from breast cancer specimens prepared from formalin fixed paraffin-embedded (FFPE) tissue and stained using Hematoxylin & Eosin (H&E) stains. The device provides prognostic risk estimates which are intended to assist physicians with prognostic risk-based decisions along with other clinicopathological factors. The device is not intended to determine a clinical diagnosis.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

510(k) clearances, last 3 years (1)

Last three years. Most recent: 2026-05-04.

NumberDecision dateApplicantDevice name
K2541152026-05-04Artera, Inc.ArteraAI Breast
Official FDA classification page: SHW
Classification and pathway per current FDA publications. Data from openFDA (CC0).